- Japan
- /
- Medical Equipment
- /
- TSE:4549
Additional Considerations Required While Assessing Eiken Chemical's (TSE:4549) Strong Earnings
Despite posting some strong earnings, the market for Eiken Chemical Co., Ltd.'s (TSE:4549) stock hasn't moved much. Our analysis suggests that shareholders have noticed something concerning in the numbers.
The Impact Of Unusual Items On Profit
Importantly, our data indicates that Eiken Chemical's profit received a boost of JP¥1.8b in unusual items, over the last year. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And, after all, that's exactly what the accounting terminology implies. We can see that Eiken Chemical's positive unusual items were quite significant relative to its profit in the year to September 2025. As a result, we can surmise that the unusual items are making its statutory profit significantly stronger than it would otherwise be.
That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.
Our Take On Eiken Chemical's Profit Performance
As we discussed above, we think the significant positive unusual item makes Eiken Chemical's earnings a poor guide to its underlying profitability. As a result, we think it may well be the case that Eiken Chemical's underlying earnings power is lower than its statutory profit. The good news is that, its earnings per share increased by 78% in the last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. While conducting our analysis, we found that Eiken Chemical has 2 warning signs and it would be unwise to ignore them.
This note has only looked at a single factor that sheds light on the nature of Eiken Chemical's profit. But there are plenty of other ways to inform your opinion of a company. For example, many people consider a high return on equity as an indication of favorable business economics, while others like to 'follow the money' and search out stocks that insiders are buying. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.
Valuation is complex, but we're here to simplify it.
Discover if Eiken Chemical might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About TSE:4549
Eiken Chemical
Engages in the manufacture and sale of clinical diagnostics in Japan.
Excellent balance sheet with acceptable track record.
Similar Companies
Market Insights
Community Narratives

